RVMD
Revolution Medicines Inc
196.90$
+0.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Investor relations
Report Dates
Investor relations overview for Revolution Medicines Inc (RVMD): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.
Next report
11/04/2026
Last report
08/05/2026
EPS estimate beaten
Full history
5 of 28 quarters (18%)
Last 16 quarters
4 of 16 quarters (25%)
Earnings Call Transcripts
- 08/05/2026 Earnings Call Q2 2026 Open →
- 05/06/2026 Earnings Call Q1 2026 Open →
- 02/25/2026 Earnings Call Q4 2025 Open →
- 11/05/2025 Earnings Call Q3 2025 Open →
- 08/07/2025 Earnings Call Q2 2025 Open →
- 05/07/2025 Earnings Call Q1 2025 Open →
- 02/27/2025 Earnings Call Q4 2024 Open →
- 11/06/2024 Earnings Call Q3 2024 Open →
- 08/11/2024 Earnings Call Q2 2024 Open →
- 05/08/2024 Earnings Call Q1 2024 Open →
- 02/26/2024 Earnings Call Q4 2023 Open →
- 11/06/2023 Earnings Call Q3 2023 Open →
- 08/08/2023 Earnings Call Q2 2023 Open →
- 05/08/2023 Earnings Call Q1 2023 Open →
- 02/27/2023 Earnings Call Q4 2022 Open →
News on This Stock
- 09/01/2026 Revolution Medicines, Inc. (RVMD): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant · sec.gov Open ↗
- 08/26/2026 Revolution Medicines, Inc. (RVMD): Other Events · sec.gov Open ↗
- 08/05/2026 Revolution Medicines, Inc. (RVMD): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.